How effective is Singulair for Gastroesophageal Reflux Disease? (by duration, gender, age)
Summary:
Overall ratings: 4/5 Long term ratings: 3.5/5
This is a phase IV clinical study of how effective Singulair (montelukast sodium) is for Gastroesophageal reflux disease and for what kind of people. The study is created by eHealthMe from 3 Singulair users and is updated continuously.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people are studied for taking Singulair in Gastroesophageal reflux disease
What is Singulair?
Singulair has active ingredients of montelukast sodium. It is used in asthma. Currently, eHealthMe is studying from 124,066 Singulair users.
What is Gastroesophageal reflux disease?
Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 3,781 drugs and 3,371 conditions by eHealthMe. Currently, we are studying 434,453 people who have Gastroesophageal reflux disease.
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Singulair effectiveness for Gastroesophageal reflux disease (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 0
Gender of people who take Singulair for Gastroesophageal reflux disease *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Singulair for Gastroesophageal reflux disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 0.0 %
Who find Singulair more effective for Gastroesophageal Reflux Disease?
Gender of people who take Singulair for Gastroesophageal reflux disease *:
- female: 50 %
- male: 50 %
Age of people who take Singulair for Gastroesophageal reflux disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Singulair?
- You can start a phase IV clinical trial to monitor Singulair safety and effectiveness.How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of:
- Singulair (124,066 reports)
Treatments, associated drugs and conditions:
- Gastroesophageal reflux disease (434,453 reports)
How the study uses the data?
The study is based on montelukast sodium (the active ingredients of Singulair) and Singulair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gemcitabine and Hypertransaminasaemia - 6 seconds ago
- Xeloda and Flonase Allergy Relief drug interaction - 8 seconds ago
- Vraylar and Drug Hypersensitivity - 16 seconds ago
- Cholestyramine and Cardiac Failure - 26 seconds ago
- Videx and Hypotonia - 26 seconds ago
- Odefsey and Divalproex drug interaction - 31 seconds ago
- Lexapro and Psoriatic Arthropathy Aggravated - 35 seconds ago
- Enbrel and Ovarian Cysts - 42 seconds ago
- Arimidex and Stomatitis - 47 seconds ago
- Oxycodone And Acetaminophen and Gaba drug interaction - a minute ago